[go: up one dir, main page]

AU2001240543A1 - Cytostatic agent glycoconjugate - Google Patents

Cytostatic agent glycoconjugate

Info

Publication number
AU2001240543A1
AU2001240543A1 AU2001240543A AU4054301A AU2001240543A1 AU 2001240543 A1 AU2001240543 A1 AU 2001240543A1 AU 2001240543 A AU2001240543 A AU 2001240543A AU 4054301 A AU4054301 A AU 4054301A AU 2001240543 A1 AU2001240543 A1 AU 2001240543A1
Authority
AU
Australia
Prior art keywords
glycoconjugate
cytostatic agent
cytostatic
agent
agent glycoconjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240543A
Inventor
Dr. Jorg Baumgarten
Hans-Georg Lerchen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001240543A1 publication Critical patent/AU2001240543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/003Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001240543A 2000-02-07 2001-01-25 Cytostatic agent glycoconjugate Abandoned AU2001240543A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10005275 2000-02-07
DE10005275A DE10005275A1 (en) 2000-02-07 2000-02-07 Novel glycoconjugates
PCT/EP2001/000793 WO2001058932A1 (en) 2000-02-07 2001-01-25 Cytostatic agent glycoconjugate

Publications (1)

Publication Number Publication Date
AU2001240543A1 true AU2001240543A1 (en) 2001-08-20

Family

ID=7630059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240543A Abandoned AU2001240543A1 (en) 2000-02-07 2001-01-25 Cytostatic agent glycoconjugate

Country Status (3)

Country Link
AU (1) AU2001240543A1 (en)
DE (1) DE10005275A1 (en)
WO (1) WO2001058932A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
RU2696487C2 (en) * 2013-03-06 2019-08-02 Аллерган, Инк. Using formylpeptide receptor 2 agonists for treating dermatologic diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4106101A1 (en) * 1991-02-27 1992-09-03 Bayer Ag FUCOSE-MARKED CYTOSTATICS
IL105503A (en) * 1992-04-28 1999-05-09 Astra Ab Peptide-carbohydrate conjugates capable of generating t cell immunity
DE4436164A1 (en) * 1994-10-10 1996-04-11 Hoechst Ag New conjugates of tetra:carbohydrate and amide-linked peptide or dye etc.
DE19512484A1 (en) * 1995-04-04 1996-10-17 Bayer Ag Carbohydrate modified cytostatics
JP2001504453A (en) * 1996-09-30 2001-04-03 バイエル・アクチエンゲゼルシヤフト Glycoconjugates from modified camptothecin derivatives (20-O-linked)
ID23424A (en) * 1997-05-14 2000-04-20 Bayer Ag GLIKOKONJUGUS OF 20 (S) -CAMPTOTESIN

Also Published As

Publication number Publication date
WO2001058932A1 (en) 2001-08-16
DE10005275A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2002224595A1 (en) Antitumor agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU4647601A (en) Vascular device
AU2001280598A1 (en) Anti-occlusion catheter
EP1151667A3 (en) Plant-activating agent
AU2001258349A1 (en) Bisacylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002330717A1 (en) Monosaccharide derivatives
AU1554301A (en) Radioprotecting agent
AU2001234178A1 (en) Modified bdnf
AU2001232244A1 (en) Drug comprising combination
AU2001246864A1 (en) Hypotensors
AU2001240543A1 (en) Cytostatic agent glycoconjugate
AU2001226668A1 (en) Crankshaft-starter-generator
EP1201403A3 (en) Electrofusible units
AU2001275696A1 (en) Therapeutic agent
AUPR024300A0 (en) Tissue bonding agent
AU2001260192A1 (en) Glycinamides